Community Medical School
Designed to share the medical learning experience with our greater community, Community Medical School is a public lecture series featuring relevant topics presented by UVM/The University of Vermont Medical Center faculty experienced with delivering scientific information in an engaging, easy-to-understand manner.
Community Medical School is held in Carpenter Auditorium from 6:00-7:30 pm, includig a Q+A Session.
Spring 2015 Community Medical School presentations include the following presentations:
March 3 - The Final Chapter: End-of-Life Decisions and Care
Zail Berry, M.D., M.P.H., Associate Professor of Medicine
Knowing what to expect at the end-of-life -- for both patients and loved ones -- can help ease the process. Gain an understanding of what end-of-life care involves, the options available, and how to best ensure a positive experience.
April 7 - Saving Lives: Kidney and Pancreas Transplants
Carlos Marroquin, M.D., Professor of Surgery
The field of transplant surgery is evolving at a tremendous rate and has experienced enormous success, with many lives saved, lengthened or improved thanks to the generosity of organ donors. Find out which health conditions can lead to a need for a transplant, how surgeons perform kidney and pancreas transplants, and details about post-care for transplant recipients.
May 5 - More Than a Sunburn: New Developments in the Diagnosis and Treatment of Skin Cancer
Glen Goldman, M.D., Professor of Medicine
Skin cancer is the most common cancer diagnosed in the United States and Vermont is among a dozen or so states with the highest incidence rate of its deadliest form -- melanoma. Learn about the causes of skin cancer, who is most at risk, and how to prevent and treat it.
June 2 - Opening Hearts: The TAVR Procedure for Aortic Stenosis
Harold Dauerman, M.D., Professor of Medicine
Aortic stenosis -- a severe narrowing of the aortic valve -- can lead to chest pain, shortness of breath and death due to heart failure. Learn about treatment options and outcomes for this condition, including a new FDA-approved procedure tested at UVM called transcatheter aortic valve replacement (TAVR) that uses catheters instead of open heart surgery to replace heart valves.
Last modified February 17 2015 10:11 AM